Life science News and Research

RSS

Roche NimbleGen to implement GMP for DNA microarrays suite

Roche NimbleGen, announced today a company-wide initiative to implement Good Manufacturing Processes (GMP) for its suite of DNA microarrays. The implementation of GMP will cover the full scope of processes from development through manufacturing and will include all locations. The company plans on achieving GMP compliance followed by subsequent submission for clearance or approval of select array products to the US Food and Drug Administration.

8 Apr 2010

Biocartis closes Series 'B' equity financing round

Biocartis SA, a biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully integrated molecular diagnostics based on its proprietary micro-technology and sample preparation platforms, today announced the successful closing of a Series B equity financing round. The Company raised EUR 30 million (~ USD 41.3 million) from its current shareholder base of leading life science investors and two new strategic investors from the pharmaceutical/diagnostic industry.

8 Apr 2010

Raptor Pharmaceutical engages The Trout Group for strategic advisory and investor relations services

Raptor Pharmaceutical Corp., today announced the engagement of The Trout Group LLC, a leading New York-based investor relations and strategic advisory firm. The Trout Group will work with Raptor to facilitate the Company's exposure to the international capital markets and coordinate their communications with investors worldwide.

7 Apr 2010

TD2 to join GPEC at BayBio2010 to spur Arizona's bioscience industry

Scottsdale-based TGen Drug Development will join the Greater Phoenix Economic Council this week at BayBio2010 in an effort to spur Arizona's bioscience industry.

7 Apr 2010

TAP to showcase performance of Fill-It dispensing system at SBS Conference

The Automation Partnership, a world leader in the design and development of innovative automation for life science applications, announces it will be showcasing the performance of its Fill-It™, benchtop automated dispensing system with a fun "Man versus Fill-It Challenge" on Booth 517 at the Society of Biomolecular Screening Conference, on April 11-15.

6 Apr 2010

Isis Pharmaceuticals to lease new 176,000 square foot research facility from BioMed Realty Trust

BioMed Realty Trust, Inc. today announced that it has expanded its strategic real estate partnership with Isis Pharmaceuticals, Inc. BioMed extended its lease for Isis' current facility at Faraday Avenue in Carlsbad, California and added a lease for a new build-to-suit project, increasing the total leased space to approximately 204,700 square feet.

5 Apr 2010

Aris Global introduces solution suite for integrating data from EDC and clinical safety

Aris Global, a leading provider of software solutions for the life sciences industry, today introduced Total Clinical 2.0, an integrated solution suite designed to help life science organizations enter clinical safety data once and share seamlessly across their enterprise. Total Clinical is available on a hosted, managed platform and includes a full range of delivery and support services.

5 Apr 2010

AllCells expands office, laboratory production space and staff

AllCells LLC, a leading supplier of primary cell types, today announced it has completed its expansion into 10,000 additional square feet of office and laboratory production space located in Emeryville, California.

5 Apr 2010

Altheos to fund development of ATS907 Rho-kinase inhibitor with completed $20M Series A financing

Altheos, Inc., a privately held early-stage biopharmaceutical company, announced today that it has completed a $20 million Series A financing led by Bay City Capital. New investors Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital also joined the round. The financing will be used primarily for the development of ATS907, a selective Rho-kinase inhibitor Altheos licensed from Japanese pharmaceutical company Asahi Kasei Pharma. The license also includes a series of highly active compounds (AK138 series) specifically for topical treatment for glaucoma.

5 Apr 2010

Ricerca Biosciences, Life Science Partner announce business development agreement

Ricerca Biosciences, a preclinical contract research drug development company, is pleased to announce a business development agreement with Life Science Partner (LSP) Co., Ltd., of Tokyo, Japan. Ricerca offers a unique spectrum of services for the areas of agrochemical registration, environmental analysis and pre-investigational new drug (IND) biopharmaceutical registration.

1 Apr 2010

Silicon Valley Bank provides new $10M credit facility to Solta Medical

Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide, added a new $10 million term loan to existing credit facilities for Solta Medical, a global leader in the medical aesthetics market. The additional term loan increases Solta Medical's credit facilities with Silicon Valley Bank to a total of $22 million. Solta Medical would expect to use the additional facility to pursue strategic initiatives.

1 Apr 2010

Symyx Technologies forms alliance with Pistoia Alliance

Symyx Technologies, Inc. today announced it has joined the Pistoia Alliance, a non-profit group that promotes collaboration to streamline non-competitive elements of pharmaceutical and life science discovery workflows. The alliance was initially formed by major global pharmaceutical companies including Pfizer, GlaxoSmithKline, Novartis, and AstraZeneca.

1 Apr 2010

Bioheart presents cutting edge therapies at 2010 Translational Regenerative Medicine Forum

Bioheart, Inc., announced today that Dr. Karl E. Groth, the Company's Chairman and CEO will speak at the 2010 Translational Regenerative Medicine Forum in Winston-Salem, North Carolina, on April 8. Dr. Groth will discuss Bioheart's cell therapies for Congestive Heart Failure.

31 Mar 2010

International pharmaceutical company orders Microsoft Dynamics AX for Process Industries from Acando

“Acando has extensive experience from projects in the life science sector. When we combine that with our deep application knowledge, we are hard to beat”

31 Mar 2010

Reverse Medical closes Series-B private equity financing

Reverse Medical Corporation announced today the closing of their Series-B private equity financing. The Company raised $14 million from new investors Wexford Capital, Getz Bros., BioStar Ventures, Early Stage Partners and Emergent Medical Partners.

31 Mar 2010

New Prestige Antibodies powered by Atlas Antibodies added to Sigma Life Science's portfolio

Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced that it has added 2,200 new Prestige Antibodies® powered by Atlas Antibodies to its industry-leading portfolio.

From Atlas Antibodies 29 Mar 2010

LSI's upcoming Emerging Medical Technologies Spotlight: 30 device companies to be showcased

Life Science Intelligence (LSI) announced today that more than 30 medical device companies with emerging technologies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on May 12, 2010 at 11 a.m. Eastern, sponsored by Rutan, Orange Coast Medical Ventures, and Medical Capital Advisors.

27 Mar 2010

Methuselah Foundation, Silverstone Solutions partner to create online NewOrgan Registry

Methuselah Foundation, a medical non-profit dedicated to extending healthy human life, today announced that it has made an investment in Silverstone Solutions, Inc., a San Francisco-based innovator in life science computing.

27 Mar 2010

Ontario announces increase in budget for research and innovation, OBIO applauds

Urgently needed capital should become more accessible to Ontario’s bioscience companies and help create jobs in the biotechnology sector, thanks to Ontario’s 2010 budget. An announced increase in the budget of the Ministry of Research and Innovation coupled with anticipated adjustments to existing funding programs designed to encourage research and innovation are applauded by Ontario Bioscience Industry Organization (OBIO).

27 Mar 2010

Market update on CBI's planned acquisition of Shanghai-based GL-Biochem

Commonwealth Biotechnologies, Inc. is pleased to provide this market update about its planned acquisition of Shanghai-based GL-Biochem and its associated businesses, one of the largest global suppliers of research-grade peptide products and peptide reagents.

27 Mar 2010

Life science News and Research

Roche NimbleGen to implement GMP for DNA microarrays suite

Biocartis closes Series 'B' equity financing round

Raptor Pharmaceutical engages The Trout Group for strategic advisory and investor relations services

TD2 to join GPEC at BayBio2010 to spur Arizona's bioscience industry

TAP to showcase performance of Fill-It dispensing system at SBS Conference

Isis Pharmaceuticals to lease new 176,000 square foot research facility from BioMed Realty Trust

Aris Global introduces solution suite for integrating data from EDC and clinical safety

AllCells expands office, laboratory production space and staff

Altheos to fund development of ATS907 Rho-kinase inhibitor with completed $20M Series A financing

Ricerca Biosciences, Life Science Partner announce business development agreement

Silicon Valley Bank provides new $10M credit facility to Solta Medical

Symyx Technologies forms alliance with Pistoia Alliance

Bioheart presents cutting edge therapies at 2010 Translational Regenerative Medicine Forum

International pharmaceutical company orders Microsoft Dynamics AX for Process Industries from Acando

Reverse Medical closes Series-B private equity financing

New Prestige Antibodies powered by Atlas Antibodies added to Sigma Life Science's portfolio

LSI's upcoming Emerging Medical Technologies Spotlight: 30 device companies to be showcased

Methuselah Foundation, Silverstone Solutions partner to create online NewOrgan Registry

Ontario announces increase in budget for research and innovation, OBIO applauds

Market update on CBI's planned acquisition of Shanghai-based GL-Biochem

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News